U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07091357) titled 'A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis' on July 21.

Brief Summary: This is a trial to evaluate the safety and efficacy of SHR-1819 injection in the treatment of patients with seasonal allergic rhinitis.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Seasonal Allergic Rhinitis

Intervention: DRUG: SHR-1819 Injection

SHR-1819 injection.

DRUG: SHR-1819 Injection Placebo

SHR-1819 injection placebo.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Published by H...